Stay updated on Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedRevision: v3.5.0 was added; Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check46 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check60 days agoChange DetectedSponsor and affiliated institutions names updated to the official branding: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University and Thomas Jefferson University (Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University) replace the previous names.SummaryDifference0.3%

- Check74 days agoChange DetectedAdded Revision: v3.4.2; removed Revision: v3.4.1 and the government funding status notice; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedA site-wide funding-status notice was added and the page revision updated to v3.4.1, replacing the previous v3.4.0 reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.